Actelion Ltd.
is a leading
biopharmaceutical
company focused
on the discovery,
development
and commercialization
of innovative drugs
for diseases
with significant
unmet medical needs.

Actelion delivers strong half year operational and financial results

Jean-Paul Clozel, CEO “In the first half of 2014
we have made great strides in delivering on
our strategy; by growing our PAH franchise,
by advancing our specialty franchises and
by optimizing our profitability.”

Jean-Paul Clozel, CEO “In the first half of 2014
we have made great strides in delivering on
our strategy; by growing our PAH franchise,
by advancing our specialty franchises and
by optimizing our profitability.”